Characteristics and Lipid Distribution of a Large, High‐Risk, Hypertensive Population: The Lipid‐Lowering Component of the Antihypertensive and Lipid‐Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)
Vasilios Papademetriou(Hippocration General Hospital), Gabriel B. Habib(Michael E. DeBakey VA Medical Center), Therese S. Geraci, Linda B. Piller, Brian Sumner(Sinai Hospital), Nathan D. Wong(University of California San Diego), David Gordon(Universidade Federal de Ouro Preto), Charles E. Ford(The University of Texas Health Science Center at Houston), L. Julian Haywood, Chuke Nwachuku(National Heart Lung and Blood Institute), Efrain Reisin(Louisiana State University Health Sciences Center New Orleans), Puneet Narayan(Veterans Health Administration), Thomas J. Hartney
Cited by 15
Related Papers
<i>Consed:</i> A Graphical Tool for Sequence Finishing
|Genome Research|1998|3.3k
A Randomized Trial of Low-Dose Aspirin in the Primary Prevention of Cardiovascular Disease in Women
|New England Journal of Medicine|2005|2k
Vitamin D Supplements and Prevention of Cancer and Cardiovascular Disease
|New England Journal of Medicine|2018|1.6k
Marine n−3 Fatty Acids and Prevention of Cardiovascular Disease and Cancer
|New England Journal of Medicine|2018|975